Dudediligence.

Harmony Biosciences Holdings, Inc

HRMYNASDAQ · Pharmaceutical Preparations
Write an idea

Insiders

Last 12 months

Sales planned on beside the trades reported on , and whether each names a .

Planned ·

$39.6M

19 notices · 1,054,962 sh

Oct 2025 to Oct 2026

Reported ·

$2,843,001

6 sales · 0 buys

Oct 2025 to Jun 2026

The two figures cover different periods.

All 6 reported sales carry the 10b5-1 box. Together they are 0.13% of the shares on issue.

PLANNED · FORM 144Oct 2025 to Oct 2026REPORTED · FORM 4Oct 2025 to Jun 2026N2025DJ2026FMAMJJASO2026-09-18: KUMAR BUDUR, Form 1442026-09-17: KUMAR BUDUR, Form 1442026-09-16: KUMAR BUDUR, Form 1442026-09-08: KUMAR BUDUR, Form 1442026-09-04: KUMAR BUDUR, Form 1442026-08-07: VALOR IV PHARMA HOLDINGS LLC, Form 1442026-07-02: SANDIP KAPADIA, Form 1442026-06-30: SANDIP KAPADIA, Form 1442026-06-26: SANDIP KAPADIA, Form 1442026-06-24: SANDIP KAPADIA, Form 1442026-06-09: SANDIP KAPADIA, Form 1442026-06-05: SANDIP KAPADIA, Form 1442026-06-04: SANDIP KAPADIA, Form 1442026-05-08: SANDIP KAPADIA, Form 1442026-01-26: SANDIP KAPADIA, Form 1442026-01-15: SANDIP KAPADIA, Form 1442025-12-12: JEFFREY M DAYNO, Form 1442025-12-05: SANDIP KAPADIA, Form 1442025-11-21: SANDIP KAPADIA, Form 1442025-11-21: Kapadia Sandip, sold2025-12-05: Kapadia Sandip, sold2025-12-12: Dayno Jeffrey M., sold2026-01-15: Kapadia Sandip, sold2026-01-26: Kapadia Sandip, sold
under a no plan named▼ salesize is dollars

Form 144 notices, newest first

2026-09-18KUMAR BUDUR, CHIEF MEDICAL OFFICER$1,532,314
35,852 shplan 2026-06-05Form 4s on file end Jun 23144 ↗
2026-09-17KUMAR BUDUR, CHIEF MEDICAL OFFICER$33,768
800 shplan 2026-06-05Form 4s on file end Jun 23144 ↗
2026-09-16KUMAR BUDUR, CHIEF MEDICAL OFFICER$75,906
1,800 shplan 2026-06-05Form 4s on file end Jun 23144 ↗
2026-09-08KUMAR BUDUR, CHIEF MEDICAL OFFICER$1,202,182
28,454 shplan 2026-06-05Form 4s on file end Jun 23144 ↗
2026-09-04KUMAR BUDUR, CHIEF MEDICAL OFFICER$230,230
5,500 shplan 2026-06-05Form 4s on file end Jun 23144 ↗
2026-08-07VALOR IV PHARMA HOLDINGS LLC, Director$26.6M
700,883 shno plan dateForm 4s on file end Jun 23144 ↗
2026-07-02SANDIP KAPADIA, CHIEF FINANCIAL OFFICER$924,008
25,000 shplan 2025-08-13Form 4s on file end Jun 23144 ↗
2026-06-30SANDIP KAPADIA, CHIEF FINANCIAL OFFICER$1,803,825
50,000 shplan 2025-08-13Form 4s on file end Jun 23144 ↗
2026-06-26SANDIP KAPADIA, CHIEF FINANCIAL OFFICER$1,606,824
45,594 shplan 2025-08-13Form 4s on file end Jun 23144 ↗
2026-06-24SANDIP KAPADIA, CHIEF FINANCIAL OFFICER$154,302
4,406 shplan 2025-08-13Form 4s on file end Jun 23144 ↗
2026-06-09SANDIP KAPADIA, CHIEF FINANCIAL OFFICER$943,264
27,960 shplan 2025-08-13Form 4s on file end Jun 23144 ↗
2026-06-05SANDIP KAPADIA, CHIEF FINANCIAL OFFICER$69,504
2,101 shplan 2025-08-13Form 4s on file end Jun 23144 ↗
2026-06-04SANDIP KAPADIA, CHIEF FINANCIAL OFFICER$233,232
7,064 shplan 2025-08-13Form 4s on file end Jun 23144 ↗
2026-05-08SANDIP KAPADIA, CHIEF FINANCIAL OFFICER$1,433,056
45,481 shplan 2025-08-13Form 4s on file end Jun 23144 ↗
2026-01-26SANDIP KAPADIA, CHIEF FINANCIAL OFFICER$137,928
3,746 shplan 2025-08-06144 ↗
Form 4, 2026-01-28: sold 3,746 at $37.15 Form 4 ↗
2026-01-15SANDIP KAPADIA, CHIEF FINANCIAL OFFICER$755,434
20,961 shplan 2025-08-06144 ↗
Form 4, 2026-01-20: sold 20,961 at $35.92 Form 4 ↗
2025-12-12JEFFREY M DAYNO, PRESIDENT, CEO$1,026,687
25,933 shplan 2024-09-13144 ↗
Form 4, 2025-12-17: sold 25,933 at $40.11 Form 4 ↗
2025-12-05SANDIP KAPADIA, CHIEF FINANCIAL OFFICER$765,000
20,000 shplan 2025-03-04144 ↗
Form 4, 2025-12-09: sold 20,000 at $39.54 Form 4 ↗
2025-11-21SANDIP KAPADIA, CHIEF FINANCIAL OFFICER$114,428
3,427 shplan 2025-03-04144 ↗
Form 4, 2025-11-25: sold 3,427 at $35.00 Form 4 ↗